Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: A prospective cohort study

BACKGROUND: Renin-angiotensin-system inhibitors (RASi), that include angiotensin converting enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) reduce proteinuria, delay chronic kidney disease (CKD) progression, protect against cardiovascular events and heart failure hospitalizations....

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Aimin, Shi, Mai, Lau, Eric S.H., Wu, Hongjiang, Zhang, Xinge, Fan, Baoqi, Kong, Alice P.S., Luk, Andrea O.Y., Ma, Ronald C.W., Chan, Juliana C.N., Chow, Elaine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706514/
https://www.ncbi.nlm.nih.gov/pubmed/36457651
http://dx.doi.org/10.1016/j.eclinm.2022.101751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706514/
https://www.ncbi.nlm.nih.gov/pubmed/36457651
http://dx.doi.org/10.1016/j.eclinm.2022.101751

Ejemplares similares